Review

AbstrAct background
The importance of measuring the quality of end-of-life care provision is undisputed, but determining how best to achieve this is yet to be confirmed. This study sought to identify and describe national end-oflife care quality indicators and supporting policies used by countries leading in their end-of-life care provision. Methods A systematic environmental scan that included a web search to identify relevant national policies and indicators; hand searching for additional materials; information from experts listed for the top 10 (n=15) countries ranked in the 'quality of care' category of the 2015 Quality of Death Index study; and snowballing from Index experts. Findings Ten countries (66%) have national policy support for end-of-life care measurement, five have national indicator sets, with two indicator sets suitable for all service providers. No countries mandate indicator use, and there is limited evidence of consumer engagement in development of indicators. Two thirds of the 128 identified indicators are outcomes measures (62%), and 38% are process measures. Most indicators pertain to symptom management (38%), social care (32%) or care delivery (27%). Interpretations Measurement of end-of-life care quality varies globally and rarely covers all care domains or service providers. There is a need to reduce duplication of indicator development, involve consumers, consider all care providers and ensure measurable and relevant indicators to improve end-of-life care experiences for patients and families.
IntroductIon
The importance of measuring the quality of end-of-life care is well established and central to informing better clinical care, research, policy reform and service commissioning. [1] [2] [3] [4] [5] For over two decades, measuring the quality of end-of-life care through clinically meaningful standards, 5 indicators and data collection tools has been recommended. 6 These terms have been used interchangeably but in this article the following definitions apply: 'standard' is an agreed and preferably evidence-based process that should be undertaken or outcome to be achieved for a defined circumstance, symptom, sign or diagnosis 7 ; 'indicator' is a measurable statement 'with explicit criteria for inclusion, exclusion, time frame and setting' (p. 79) 7 ; 'tool' is a method and/or instrument used to gather data to inform a quality indicator and standard 7 8 and 'measure' is used only as a verb to avoid ambiguity.
Progressing measurement of end-of-life care quality would benefit from: collation, analysis and adaptation of current indicators for use across different societies and health systems, cultures, care settings and diagnoses 2 3 9 10 ; development of indicators where gaps exist 2 3 11 and decreased variation in indicators to enable greater comparative and collaborative opportunities. 3 9 Given end-of-life care complexity, there is a need for suites of indicators that reflect multiple domains of care 1 2 5 as well as measuring structures, process and outcomes to elucidate the relationship between these. 10 11 A recent international review of quality indicators for end-of-life care was published in 2013 and concluded that the large number of indicators developed over the preceding years had been subject to limitations in quality and capacity for clinical implementation. 10 We went beyond this work by examining supporting policies. 10 Better understanding how Review countries are undertaking national quality measurement of end-of-life care to drive improvements and commissioning of new services is critical to improving care experiences for those who require it.
AIM
To identify and describe national quality indicators and supporting policies used by countries leading in their provision of quality end-of-life care.
Method design
A systematic environmental scan, undertaken from November 2016 to February 2017.
eligibility criteria
Data pertaining to a country listed in the top 10 countries (n=15) ranked in the 'quality of care' category within the 2015 Quality of Death Index study 12 were eligible for inclusion. This design allowed analysis of methods used to support system-wide end-of-life care improvements and the identification of indicators used by both specialist and/or primary care providers. This article defines end-of-life care as care provided to a person living with, and impaired by, a progressive and eventually fatal condition 13 ; specialist palliative care as care provided by clinicians whose substantive role is within palliative care 14 ; and primary care providers as any clinician providing care to those with end-of-life care needs, where their substantive work is not within specialist palliative care. This includes, but is not limited to, general practitioners, community nurses, staff of aged care facilities and acute care hospitals as well as specialist staff (eg, oncologists, geriatricians, renal, cardiac or respiratory physicians). 14 data sources A systematic web search with predefined search terms and review of the first 10 web pages for each search, was undertaken. This search was designed to identify peer-reviewed publications, non-peer-reviewed reports, policies, standards and/or resources relevant to measuring quality of end-of-life care. Once this was completed, additional details from the countries ranked in the top 10 of the 'quality of care' domain of The 2015 Quality of Death Index: Ranking palliative care across the world 12 ('Index') were sought via (i) a systematic Google search to identify all relevant national policy and indicators, augmented with handsearching of retrieved documents to identify additional sources for review; and (ii) listed key informants ('experts') named in the Index 12 who were emailed a set of standard questions about the availability and implementation of quality indicators in their country.
Experts identified in the 'Index' 12 were asked to address the following three questions: Concurrent data analysis occurred via a two-step process: (i) analysis of supporting policies and national approaches to quality measurement of end-of-life care within each participating country and (ii) analysis of the nationally available end-of-life care indicators from participating countries. Mapping was Review completed to identify availability of national standards, national quality indicators, whether they were designed for specialist palliative care or primary care providers and whether they were supported by national policy and/or mandated for use. Information provided by Index experts was summarised to provide a country-specific overview and to describe any identified measurement barriers and enablers. Identified indicators were categorised in accordance with the Donabedian model 15 and the US National Consensus Project Guidelines 16 ('US Guidelines'), mapped to the recent systematic review of available indicators 10 and summarised via descriptive analysis. The Donabedian model 15 enabled collation of indicator types (structure, process or outcome), independently categorised by two researchers (CV and TL). Adopting the approach used by two recent systematic reviews, 10 11 all indicators were mapped independently by two researchers (CV and TL) to the 'US Guidelines' domains. 16 Mapping to those indicators reported in the most recent systematic review 10 was then completed (CV) with 10% of this work independently coded and checked for accuracy (JP). Lastly, to summarise the content descriptively, we grouped the indicators into measurement domains (CV and TL). Any disagreement in categorisation, mapping or grouping of indicators was discussed to ensure consensus. results Seven Google searches generated 10 items per web page across 10 web pages per search, resulting in a review of 700 items with 99 items meeting the inclusion criteria, including ► 28 peer-reviewed manuscripts; ► 40 policy/report documents from the UK (n=15; includes the UK n=11, England n=2, Scotland n=2), Australia (n=14), the USA (n=6), Ireland (n=3), Canada (n=1), global (n=1); ► 31 web pages-the USA (n=16), Australia (n=7), the UK (n=6), Canada (n=2)-resulting in an additional 89 documents downloaded for review.
Handsearching generated another 68 documents for inclusion. Targeted searches of the 15 countries participating in this study led to an additional 49 documents for review, a total of 274 documents included overall (refer figure 1).
country experts
Of the 39 experts identified from the 15 included countries, 18 responded (46% response rate) with an additional 46 nominees contacted, with 27 providing additional data (59% response rate) (see None of the included countries mandates the implementation of their national quality indicators with all relying on policy guidance to spur measurement of the quality of end-of-life care. In 8 (53%) of the 15 included countries, policy guidance has not led to indicator development. Australia is the only country with a national policy supporting measurement of quality end-of-life care, national standards for optimal end-oflife care and a national indicator set available for use. However, these 20 indicators do not directly map to all 13 Australian palliative care standards 17 and are only applicable to specialist palliative care services.
enablers and barriers to implementing national end-of-life care quality indicators
Significant work is under way to strengthen the measurement of quality end-of-life care provision globally (online supplementary appendix 1), with four key enablers for development and implementation of national end-of-life quality indicators identified, namely 1 . national project/programme work (Australia, Belgium and the Netherlands) 2. use of mandatory accreditation frameworks (England, France, Australia and Singapore) 3. availability of a national palliative care data registry (Sweden) 4. incentivising quality indicator use (the USA).
Three main barriers were identified by experts that prevent quality measurement of end-of-life care, including 1 . lack of a national data collection system focused on quality of end-of-life care (England); 2. legal and regulatory constraints in relation to data access (England);
3. policy frameworks that focus on availability, access and activity, rather than a more holistic understanding of quality end-of-life care (England and France).
An overview and analysis of nationally available end-of-life care indicators
There are 128 indicators identified from five countries: the Netherlands (n=43), Belgium (n=31), the USA (n=25), Australia (n=20) and Sweden (n=9) (online supplementary appendix 3). The majority (62%, n=79) are outcome indicators, with the remaining (38%, n=49) classified as process indicators. No structural indicators were identified (figure 2). The majority of indicators, when mapped to the 'US Guidelines' domains, 16 refer to physical care (n=48, 38%), social care (n=41, 32%) or processes of care delivery (n=35, 27%). There are a smaller number of indicators measuring psychological (n=21, 16%), spiritual/religious care (n=21, 16%) or the quality of care throughout the dying process (n=17, 13%). Few indicators measure cultural (n=9, 7%) or ethical and legal aspects of care (n=9, 7%). Belgium and the Netherlands are the only countries with a set of indicators that map to all domains. Physical aspects of care are the major focus for Australia (n=15, 75%) and Sweden (n=6, 67%). Cultural aspects of care are never explicitly referred to, with indicators mapped to this domain measuring either quality of life, how a patient or family member was feeling, degree of preparedness for saying goodbye and perceptions of the quality of death.
Mapping the 128 national indicators (online supplementary appendix 3) to the 2013 systematic review of quality end-of-life care indicators, 10 found 32 (18%) were listed, considerable overlap in indicator availability (eg, multiple indicators measuring aspects of pain screening, assessment and/or management) with 'similar' indicators used on 73 occasions. There are 390 distinct quality indicators listed across the systematic review 10 and this study. Three of the five participating countries with national indicators sets (Australia, the Netherlands and the USA) were within the published review's indicator set. Review multiple components of care and could not be mapped to one domain. Figure 3 provides an overview of the mapping of indicators to key domains. dIscussIon This environmental scan identified wide global variability in progress towards establishing national approaches to robust, feasible and sustainable mechanisms for measurement of the quality of end-of-life care provision. [18] [19] [20] [21] Belgium and the Netherlands currently have the most comprehensive indicator sets available at national levels. However, Belgium's set is currently only for specialist palliative care providers and the Netherlands' indicator set was made available as part of a 5-year project, due for completion this year.
Indicators are currently only used by a third of countries identified as leading in end-of-life care provision, and none of the countries mandated indicator use. Two of the five indicator sets we identified were designed for use by specialist palliative care services rather than more generally measuring end-of-life care provided by primary care providers; and only two addressed all of the 'US Guidelines' domains. 16 While hospital accreditation requirements in England, France and Singapore incorporate aspects of end-of-life care, no national indicators have been developed specifically to support this process in acute care.
Enabling system-wide improvements for end-of-life care provision requires the integration of indicators into existing healthcare systems and indicators that are relevant to primary care providers and specialist palliative care providers. While Sweden reports improvements in end-of-life care resulting from integration of indicators across all care settings for all care providers, 18 their current indicator set does not cover all care domains or consider structural, process and outcomes and subsequent causal linkages. No participating countries had a comprehensive set of national end-of-life care indicators relevant to all care providers across care settings. The development and implementation of a comprehensive set of indicators would support wide-scale improvements in patient and family experiences. Given the increasing number of people living with complex illnesses, focusing indicator development only on specialist palliative care services alone reinforces the status quo and does little to highlight the need for all health systems to prioritise end-of-life care.
Debate continues as to whether indicators should be mandated or voluntary, with a recent US publication proposing that a nationally mandated approach will enable progression in measurement of, and improvements within, patient safety. 22 Without a mandated approach, our data suggest that implementation is inconsistent and/or reliant on project funding affecting sustainability and usability of data for comparative purposes. However, mechanisms to mandate need careful consideration with a specific focus on whether incentivising is useful, whether public reporting of data assists performance and whether data should be used with a punitive intention. 23 Given the aim for such reporting is to drive system-wide improvements, Review policymakers and standard enforcers are advised to consider such approaches in line with best practice for performance management. 23 However, the complexity of this work should not be underestimated. Each country has unique data collection, data regulation, policy and population requirements to consider. Nevertheless, development of national data registries, incentivising indicator use, appropriate utilisation of accreditation processes and commencing work through funded national programmes have all been highlighted as mechanisms for enabling progression in quality measurement of end-of-life care (online supplementary appendix 1).
Current development and implementation of quality indicators for end-of-life care falls short of key recommendations from a recent systematic review. 10 No national indicator sets include structural measures with recommendations highlighting the need for structure, process and outcome indicators to truly inform a review of quality end-of-life care, and advice to adapt indicators across countries to limit development of new indicators and enhance opportunities for benchmarking has not been implemented with all countries having unique sets of indicators with both duplication and heterogeneity evident. There are opportunities to learn from different approaches and indicators used, to share successes and challenges in the measurement of optimal end-of-life care and for policymakers, researchers and service commissioners to use this information in line with cultural and contextual factors at the national level.
Given the focus on person-centred care and consumer-driven healthcare, it is time that the healthcare sector also partnered with consumers to identify a set of indicators that can assist optimal end-of-life care provision across all care settings (acute, community Review and aged care) and implement these nationally so service commissioning is in line with best practice. Driving such work from a consumer perspective will ensure that all system-level improvements are in line with patient and family expectations of what constitutes good end-of-life care. 24 25 It is also timely to develop an international repository of available indicators to limit ongoing development of 'similar' indicators and inform development of indicators where these are not available (eg, cultural care). Such work could lead to international consensus on specific indicators that are of shared importance; for example, in relation to symptom management. Opportunities for collaboration and learning from other countries will flow directly from such an approach.
Crafting a set of national quality indicators that draws together key information from multiple tools in a feasible and sustainable way is complex. For an indicator set to be feasible for clinical settings, the number and frequency of measuring is an important consideration. It also requires a commitment to use existing data sources, 26 carefully consider tools that inform quality indicators and standards, 1-3 5 6 27 prioritise tools that assess consumer-identified areas of importance, 27 can be implemented into routine clinical practice 1 28 and preference patient-reported data. 1 9 29 Enabling quality measurement of end-of-life care also requires assessing the validity and usefulness of available national data sets 2 and better understanding how to use information from proxies when patients are unable to self-report. 2 Finally, ensuring a pathway between indicators and improved patient and family experience is fundamental to successfully effecting system-level improvements. 
Review strengths and limitations
The involvement of key experts from all participating countries is a strength of this study. Their contribution has ensured a realistic view of practice within the context of future plans that would not have been available from the published literature only. Furthermore, the use of standardised questions for experts and the systematic approach we used to search for and collect data limits the risk of bias. We adhered to standards for reporting a systematic review to the degree possible, recognising that such standards do not currently account for internet-inclusive searches.
The study's main limitation is that we restricted participation to the 15 countries ranked in the top 10 countries delivering quality end-of-life care according to the 'Index'. 12 Other countries may be working in this area and may have national quality indicators not included in our review. Focusing on the countries ranked in the top 10 for quality of care was intended to instil at least some confidence in the quality of policies in the absence of research evidence. Limiting our inclusion to national indicators rather than those used at local or regional levels means that we have not identified quality indicators currently used by some services. This approach enabled reviewing in line with national policy guidance and reduced contextual heterogeneity at least to some extent. While the 'US Guidelines' 16 had previously been used to map indicators to key domains, 10 11 these were hard to separate at times (eg, significant overlap between domain 1-structure and processes of care and domain 4-social aspects of care) and this led to us taking an inclusive approach. As a result, the mapping may over-represent availability of measures in some domains. Finally, similar to other reviews, this study has focused purely on quality measurement, without inclusion of safety. 3 5 10 Despite some progress noted in healthcare safety measurement over the past 15 years, considerable work is required to enable this in a systematic way 22 for people with end-of-life care needs. 30 conclusIon Measuring the quality of end-of-life care is a global priority as it is key to ensuring access to high-quality care across all settings, regardless of where you live. The collaborative development of a consumer-centred set of quality indicators, mapped to available standards and data sources, to inform local, regional and national understanding of end-of-life care provision is a good starting point to strengthen the quality and safety agenda. Indicator development that supports system-level improvements in end-of-life care provision will need to consider both primary care providers as well as specialist palliative care providers and all care settings. A collaborative approach will reduce duplication of effort, facilitate rapid transfer of learnings from key successes and provide the foundation for future benchmarking.
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